Webinar: The Diversion Gap and What to Do About It

Jenny HarlettBlog

Kit Check’s Clinical Solutions Specialist AJ Rivosecchi, Pharm.D., recently held a webinar to discuss what we call the diversion gap—the space between controlled substance dispense activity and documentation where inventory can go missing. Hosted by IHFDA, the webinar covers key findings from our 2018 Hospital Pharmacy Operations Report, especially as they relate to the opioid crisis. AJ discusses the need … Read More

HIStalk Interviews Kit Check CEO Kevin MacDonald

Ava MutchlerBlog

Kit Check CEO Kevin MacDonald was recently interviewed by HISTalk and shared some thoughts on where the company started, where it is today, and where it’s headed. “We are approaching 500 hospitals now and growing very quickly. We are thrilled that we’re now tracking more than one new medication every second, but there’s still a lot of room to grow,” commented MacDonald.

Identifying Diversion by Location — A Practical Application of Machine Learning

Doug ZurawskiBlog

In the day-to-day battle against drug diversion, most solutions look at the data to find statistical outliers. Often the focus is on clinicians who may be logging more transactions than their peers, or on medications that are administered in unusual amounts or that go missing. We can call this the “Who” and the “What.” But we really have to look … Read More

Now What? Responding to Diversion Events with Speed and Impact

Hannah ByamBlog

As the national conversation around opioid abuse continues to grow, hospitals grappling with citations, fines and the bad publicity that accompany these events are looking for solutions that can have both an immediate reduction in liability and set them up for long-term compliance and risk abatement.

Increasing scrutiny for hospital pharmacies over management and use of controlled substance inventory

Hannah ByamBlog

As the opioid epidemic continues to make headlines, hospitals are facing increasing pressure to detect and prevent controlled substance diversion. In response, the American Society of Health-System Pharmacists (ASHP) released guidelines on developing a comprehensive diversion prevention program which builds upon similar publications by the CDC, DEA and The Joint Commission. Given the risks, hospitals should heed these guidelines to ensure they have the safeguards in place to avoid similar incidents that have plagued the headlines.